n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine has been researched along with Esophageal Neoplasms in 1 studies
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine: a zinc ion chelating agent; structure given in first source
N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine : An N-substituted diamine that is ethylenediamine in which the four amino hydrogens are replaced by 2-pyridylmethyl groups.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, S | 1 |
| Cui, C | 1 |
| Luo, Y | 1 |
| Kim, SH | 1 |
| Ko, JK | 1 |
| Huo, X | 1 |
| Ma, J | 1 |
| Fu, LW | 1 |
| Souza, RF | 1 |
| Korichneva, I | 1 |
| Pan, Z | 1 |
1 other study available for n,n,n',n'-tetrakis(2-pyridylmethyl)ethylenediamine and Esophageal Neoplasms
| Article | Year |
|---|---|
Selective inhibitory effects of zinc on cell proliferation in esophageal squamous cell carcinoma through Orai1.
Topics: Amino Acid Substitution; Calcium Signaling; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Prolife | 2018 |